US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist

0.891
+0.108+13.82%

Close Nov 4 16:00 ET

0.858
-0.033-3.66%

Post 18:45 ET

1.66MMarket Cap-461P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-279.03%-1.19M

-176.35%-1.14M

-349.80%-4.54M

3.50%-63.67K

-1,122.26%-3.75M

41.34%-313.49K

-302.38%-412.68K

-55.60%-1.01M

78.82%-65.98K

-307.06K

Net income from continuing operations

-24.84%-4.17M

116.48%427.99K

38.27%-3.81M

-22.55%-2.05M

387.70%4.17M

-55.51%-3.34M

-186.25%-2.6M

-45.01%-6.18M

-22.32%-1.67M

---1.45M

Operating gains losses

-99.72%1.1K

-306.01%-1.74M

323.21%1.67M

199.06%132.6K

1,229.64%299.1K

--391.76K

--845.02K

--394.24K

---133.87K

--22.5K

Depreciation and amortization

-55.95%11.01K

-16.50%22.13K

27.40%100.37K

9.51%23.44K

30.87%25.43K

30.67%24.99K

40.85%26.5K

9.75%78.79K

16.46%21.41K

--19.44K

Other non cash items

----

-466.27%-4.27M

-1,555.63%-5M

-94.34%27.3K

51.73%334.31K

217.46%375.27K

92.67%1.16M

42.32%343.73K

--482.61K

Change In working capital

-75.07%221.24K

-97.76%16.55K

-87.97%405.36K

7.96%1.31M

-463.68%-2.53M

6.64%887.52K

17.46%739.48K

16.33%3.37M

60.47%1.21M

--695.71K

-Change in receivables

146.58%19.85K

-130.11%-84.89K

-284.63%-185.37K

-162.60%-93.32K

91.34%-12.54K

-133.20%-42.62K

-14.16%-36.89K

-85.92%100.4K

-37.30%149.08K

---144.71K

-Change in inventory

-91.40%9.36K

128.49%30.79K

2,001.00%212.75K

227.76%152.54K

188.97%59.44K

641.08%108.84K

-193.14%-108.08K

-96.76%10.13K

-4.34%46.54K

--20.57K

-Change in prepaid assets

273.12%92.67K

243.18%61.84K

-2,197.70%-522.37K

3,084.26%990.21K

-2,445.27%-1.48M

-137.40%-53.53K

166.76%18.02K

-81.67%24.9K

-292.92%-33.18K

---58.03K

-Change in payables and accrued expense

-88.80%99.36K

-97.32%22.45K

-63.21%1.05M

-67.44%272.26K

-211.90%-947.34K

103.09%887.02K

13.91%838.68K

65.70%2.86M

104.98%836.06K

--846.56K

-Change in other current liabilities

--0

-11.46%-13.65K

-7.43%-50.27K

-5.01%-13.15K

-5.00%-12.67K

-5.00%-12.21K

-15.76%-12.25K

-17.52%-46.8K

-425.12%-12.52K

---12.07K

-Change in other working capital

----

-123.52%-100K

--0

-422.66%-140K

--0

--40K

722.07%425.26K

389.21%226.1K

--43.39K

Cash from discontinued investing activities

Operating cash flow

-279.03%-1.19M

-176.35%-1.14M

-349.80%-4.54M

3.50%-63.67K

-1,122.26%-3.75M

41.34%-313.49K

-302.38%-412.68K

-55.60%-1.01M

78.82%-65.98K

---307.06K

Investing cash flow

Cash flow from continuing investing activities

-620.25%-130.56K

-198.12%-9.81K

-92.72%-115.89K

-13.50%-66.56K

-2,066.67%-27.91K

-771.07%-18.13K

-298.55%-3.29K

-69.91%-60.13K

-3,243.50%-58.65K

1.42K

Capital expenditure reported

-127.36%-27.57K

77.95%-726

-20.93%-39.98K

65.92%-10.76K

-1,072.59%-13.8K

-482.75%-12.13K

-298.55%-3.29K

-2.29%-33.06K

-1,700.17%-31.58K

--1.42K

Net PPE purchase and sale

----

---57.62K

---55.8K

---1.82K

----

--0

----

Net intangibles purchase and sale

-116.45%-12.99K

---9.09K

32.46%-18.28K

--0

---12.28K

---6K

--0

---27.07K

--0

Cash from discontinued investing activities

Investing cash flow

-620.25%-130.56K

-198.12%-9.81K

-92.72%-115.89K

-13.50%-66.56K

-2,066.67%-27.91K

-771.07%-18.13K

-298.55%-3.29K

-69.91%-60.13K

-3,243.50%-58.65K

--1.42K

Financing cash flow

Cash flow from continuing financing activities

-100.27%-865

943.54%1.9M

429.96%6.47M

5.97M

-75.12%321.07K

182.39K

99.88%1.22M

-181.85%-68.63K

Net issuance payments of debt

----

-186.98%-961.11K

--0

---1.61M

----

80.78%1.11M

--0

Net common stock issuance

--0

--1.91M

--6.45M

--0

--6.45M

--0

---185.34K

--0

Proceeds from stock option exercised by employees

--5K

--1.13M

--0

--1.13M

--0

----

Net other financing activities

98.22%-5.86K

-108.89%-16.22K

-228.89%-150.42K

--0

---3.88K

---328.93K

--182.39K

--116.71K

----

Cash from discontinued financing activities

Financing cash flow

-100.27%-865

943.54%1.9M

429.96%6.47M

--0

--5.97M

-75.12%321.07K

--182.39K

99.88%1.22M

-181.85%-68.63K

--0

Net cash flow

Beginning cash position

9,551.25%2.89M

708.90%2.14M

129.52%264.87K

404.91%2.22M

--19.07K

-72.37%29.99K

129.52%264.87K

-39.80%115.4K

30.95%439.39K

----

Current changes in cash

-12,409.58%-1.32M

422.39%753.04K

1,097.79%1.82M

32.61%-130.23K

--2.19M

---10.55K

-125.94%-233.58K

306.89%151.59K

15.75%-193.25K

----

Effect of exchange rate changes

511.23%1.54K

36.12%-824

3,007.99%61.85K

189.35%54.18K

245.58%9.34K

99.66%-374

-101.34%-1.29K

29.83%-2.13K

103.07%18.72K

---6.42K

End cash Position

8,167.45%1.58M

9,551.25%2.89M

708.90%2.14M

--2.22M

--19.07K

-72.37%29.99K

129.52%264.87K

----

Free cash flow

-297.68%-1.32M

-176.52%-1.15M

-335.36%-4.66M

-4.50%-130.23K

-1,137.07%-3.78M

38.19%-331.62K

-302.35%-415.97K

-56.34%-1.07M

60.21%-124.62K

---305.64K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-279.03%-1.19M	-176.35%-1.14M	-349.80%-4.54M	3.50%-63.67K	-1,122.26%-3.75M	41.34%-313.49K	-302.38%-412.68K	-55.60%-1.01M	78.82%-65.98K	-307.06K
Net income from continuing operations	-24.84%-4.17M	116.48%427.99K	38.27%-3.81M	-22.55%-2.05M	387.70%4.17M	-55.51%-3.34M	-186.25%-2.6M	-45.01%-6.18M	-22.32%-1.67M	---1.45M
Operating gains losses	-99.72%1.1K	-306.01%-1.74M	323.21%1.67M	199.06%132.6K	1,229.64%299.1K	--391.76K	--845.02K	--394.24K	---133.87K	--22.5K
Depreciation and amortization	-55.95%11.01K	-16.50%22.13K	27.40%100.37K	9.51%23.44K	30.87%25.43K	30.67%24.99K	40.85%26.5K	9.75%78.79K	16.46%21.41K	--19.44K
Other non cash items	----	----	-466.27%-4.27M	-1,555.63%-5M	-94.34%27.3K	51.73%334.31K	217.46%375.27K	92.67%1.16M	42.32%343.73K	--482.61K
Change In working capital	-75.07%221.24K	-97.76%16.55K	-87.97%405.36K	7.96%1.31M	-463.68%-2.53M	6.64%887.52K	17.46%739.48K	16.33%3.37M	60.47%1.21M	--695.71K
-Change in receivables	146.58%19.85K	-130.11%-84.89K	-284.63%-185.37K	-162.60%-93.32K	91.34%-12.54K	-133.20%-42.62K	-14.16%-36.89K	-85.92%100.4K	-37.30%149.08K	---144.71K
-Change in inventory	-91.40%9.36K	128.49%30.79K	2,001.00%212.75K	227.76%152.54K	188.97%59.44K	641.08%108.84K	-193.14%-108.08K	-96.76%10.13K	-4.34%46.54K	--20.57K
-Change in prepaid assets	273.12%92.67K	243.18%61.84K	-2,197.70%-522.37K	3,084.26%990.21K	-2,445.27%-1.48M	-137.40%-53.53K	166.76%18.02K	-81.67%24.9K	-292.92%-33.18K	---58.03K
-Change in payables and accrued expense	-88.80%99.36K	-97.32%22.45K	-63.21%1.05M	-67.44%272.26K	-211.90%-947.34K	103.09%887.02K	13.91%838.68K	65.70%2.86M	104.98%836.06K	--846.56K
-Change in other current liabilities	--0	-11.46%-13.65K	-7.43%-50.27K	-5.01%-13.15K	-5.00%-12.67K	-5.00%-12.21K	-15.76%-12.25K	-17.52%-46.8K	-425.12%-12.52K	---12.07K
-Change in other working capital	----	----	-123.52%-100K	--0	-422.66%-140K	--0	--40K	722.07%425.26K	389.21%226.1K	--43.39K
Cash from discontinued investing activities
Operating cash flow	-279.03%-1.19M	-176.35%-1.14M	-349.80%-4.54M	3.50%-63.67K	-1,122.26%-3.75M	41.34%-313.49K	-302.38%-412.68K	-55.60%-1.01M	78.82%-65.98K	---307.06K
Investing cash flow
Cash flow from continuing investing activities	-620.25%-130.56K	-198.12%-9.81K	-92.72%-115.89K	-13.50%-66.56K	-2,066.67%-27.91K	-771.07%-18.13K	-298.55%-3.29K	-69.91%-60.13K	-3,243.50%-58.65K	1.42K
Capital expenditure reported	-127.36%-27.57K	77.95%-726	-20.93%-39.98K	65.92%-10.76K	-1,072.59%-13.8K	-482.75%-12.13K	-298.55%-3.29K	-2.29%-33.06K	-1,700.17%-31.58K	--1.42K
Net PPE purchase and sale	----	----	---57.62K	---55.8K	---1.82K	----	----	--0	--0	----
Net intangibles purchase and sale	-116.45%-12.99K	---9.09K	32.46%-18.28K	--0	---12.28K	---6K	--0	---27.07K	---27.07K	--0
Cash from discontinued investing activities
Investing cash flow	-620.25%-130.56K	-198.12%-9.81K	-92.72%-115.89K	-13.50%-66.56K	-2,066.67%-27.91K	-771.07%-18.13K	-298.55%-3.29K	-69.91%-60.13K	-3,243.50%-58.65K	--1.42K
Financing cash flow
Cash flow from continuing financing activities	-100.27%-865	943.54%1.9M	429.96%6.47M	0	5.97M	-75.12%321.07K	182.39K	99.88%1.22M	-181.85%-68.63K	0
Net issuance payments of debt	----	----	-186.98%-961.11K	--0	---1.61M	----	----	80.78%1.11M	--0	--0
Net common stock issuance	--0	--1.91M	--6.45M	--0	--6.45M	--0	--0	--0	---185.34K	--0
Proceeds from stock option exercised by employees	--5K	--5K	--1.13M	--0	--1.13M	--0	--0	--0	--0	----
Net other financing activities	98.22%-5.86K	-108.89%-16.22K	-228.89%-150.42K	--0	---3.88K	---328.93K	--182.39K	--116.71K	----	----
Cash from discontinued financing activities
Financing cash flow	-100.27%-865	943.54%1.9M	429.96%6.47M	--0	--5.97M	-75.12%321.07K	--182.39K	99.88%1.22M	-181.85%-68.63K	--0
Net cash flow
Beginning cash position	9,551.25%2.89M	708.90%2.14M	129.52%264.87K	404.91%2.22M	--19.07K	-72.37%29.99K	129.52%264.87K	-39.80%115.4K	30.95%439.39K	----
Current changes in cash	-12,409.58%-1.32M	422.39%753.04K	1,097.79%1.82M	32.61%-130.23K	--2.19M	---10.55K	-125.94%-233.58K	306.89%151.59K	15.75%-193.25K	----
Effect of exchange rate changes	511.23%1.54K	36.12%-824	3,007.99%61.85K	189.35%54.18K	245.58%9.34K	99.66%-374	-101.34%-1.29K	29.83%-2.13K	103.07%18.72K	---6.42K
End cash Position	8,167.45%1.58M	9,551.25%2.89M	708.90%2.14M	708.90%2.14M	--2.22M	--19.07K	-72.37%29.99K	129.52%264.87K	129.52%264.87K	----
Free cash flow	-297.68%-1.32M	-176.52%-1.15M	-335.36%-4.66M	-4.50%-130.23K	-1,137.07%-3.78M	38.19%-331.62K	-302.35%-415.97K	-56.34%-1.07M	60.21%-124.62K	---305.64K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data